1 / 7

Small Cell Lung Cancer - Epidemiology Market - Global Industry Size, Share, Trends, Analysis

Download Sample Brochure @ http://tinyurl.com/hxp58oe<br><br>A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Small Cell Lung Cancer - Epidemiology Review and future opportunities are provided in the report.<br>

tharun
Télécharger la présentation

Small Cell Lung Cancer - Epidemiology Market - Global Industry Size, Share, Trends, Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EpiCast Report: Small Cell Lung Cancer - Epidemiology Forecast to 2024 Published on – 01 January, 2016 Single User Price: $3995 | No of Pages : 47 The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the EpiCast Report: Small Cell Lung Cancer - Epidemiology Forecast to 2024 development trends and marketing channels are analyzed.

  2. Summary Small Cell Lung Cancer (SCLC) is a distinct form of lung cancer that typically initially presents in the central airways before spreading to the submucosa, which leads to the narrowing of airways. SCLC is considered to be highly malignant due to its cell composition that causes faster doubling time, earlier development of metastases, and worsened prognosis when compared with other lung cancer types. SCLC is widely considered to account for 15% of all lung cancer cases, with the other lung cancer cases being predominantly caused by non-small cell lung cancer (NSCLC). SCLC is typically presented in two main stages, limited stage (LS-SCLC) and extensive stage (ES-SCLC).

  3. GlobalData’s epidemiological forecast for the diagnosed incident and the five-year diagnosed prevalent cases of SCLC in the 7MM is supported by age- and sex-specific incidence data obtained for the individual markets. Further, the analysis was strengthened by the use of a consistent methodology and definition of lung cancer for the diagnosed incident cases in the SCLC forecast, and using linear regression techniques when suitable. In addition, the forecast is based on age-, sex-, and market-specific historical data points obtained from the NCC, CI5plus, ITACAN, SEER, and ZfKD databases. The use of a consistent methodology across the 7MM to forecast the total diagnosed incident cases, and the five-year diagnosed prevalent cases of SCLC, allows for a meaningful comparison of the forecast incident cases and the forecast five- year prevalent cases of SCLC across the 7MM Click Here To Check Complete Report

  4. Scope - The Small Cell Lung Cancer (SCLC) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for RSV infection in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of the diagnosed incident cases of SCLC and the five-year diagnosed prevalent cases of SCLC segmented by sex, age (beginning at 18 years and ending at =85 years), and stage in these markets. - The SCLC epidemiology report is written and developed by Masters- and PhD-level epidemiologists. - The EpiCast Report is in-depth, high quality, transparent and market- driven, providing expert analysis of disease trends in the 10MM. Download Sample Brochure

  5. Reasons to buy The Small Cell Lung Cancer (SCLC) EpiCast report will allow you to - - Develop business strategies by understanding the trends shaping and driving the global SCLC market. - Quantify patient populations in the global SCLC market to improve product design, pricing, and launch plans. - Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for SCLC therapeutics in each of the markets covered. Make an Inquiry Before Buying

  6. Key questions answered in this report • What will the market size be in 2020 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

  7. EpiCast Report: Small Cell Lung Cancer - Epidemiology Forecast to 2024 A detailed qualitative analysis of the factors responsible for driving and restraining growth of the, EpiCast Report: Small Cell Lung Cancer - Epidemiology Forecast to 2024 and future opportunities are provided in the report. Contact: 1-302-684-6088 sales@marketintelreports.com www.marketintelreports.com Click here to order a copy of EpiCast Report: Small Cell Lung Cancer - Epidemiology Forecast to 2024

More Related